Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID | D01DTQ | ||||
| Former ID | DIB017013 | ||||
| Drug Name | PXS-2076 | ||||
| Synonyms | PXS-2000; PXS-2030; Cannabinoid CB2 agonist (rheumatoid arthritis), Pharmaxis; TNFrelease inhibitor (rheumatoid arthritis), Pharmaxis | ||||
| Indication | Rheumatoid arthritis [ICD9: 710-719, 714; ICD10:M05-M06] | Terminated | [548079] | ||
| Company | Pharmaxis Ltd | ||||
| Target and Pathway | |||||
| Target(s) | Cannabinoid receptor 2 | Target Info | Agonist | [543878] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.
